Business
Look out for the Auscann (ASX:AC8) and Cannpal (ASX:CP1) share prices post trading halt // Motley Fool Australia
The Auscann Group Holdings Ltd (ASX: AC8) and Cannpal Animal Therapeutics Ltd (ASX: CP1) share prices will be on watch tomorrow. (Assuming, of course, that the ASX system has returned to functionality by then!)
Both companies entered a trading halt on Friday, prior to revealing that Auscann has entered into a scheme implementation deed (SID) with Cannpal.
Neither company escaped the ravages of the COVID-19 market rout in February and March. But Cannpal came roaring back, with shares up 8.3% year-to-date. Auscann shareholders have had a more difficult year, with Auscann’s share price down 53.3% since 2 January. By comparison the All Ordinaries Index (ASX: XAO) is down 1.8% for the year.
What do Auscann and Cannpal do?
Auscann…
-
Noosa News18 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General22 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News8 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News19 hours ago‘Low morale, decreasing trust in leadership’: Top cop’s stark warning